Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 3/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | RECQL | P46063 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | USP2 | O75604 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.62 |
| ▸ | CASP1 | P29466 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.62 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.62 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 2/20 | 0.57 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.54 |
| ▸ | RARB | P10826 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.50 |
| ▸ | MLNR | O43193 | 1/20 | 0.50 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetraethylene Glycol SCHEMBL2484429 | 0.98 | ALDH1A1 (0.65) | LTA4HALDH1A1RECQLMEN1USP2 | |
| Triethylene Glycol SCHEMBL2487711 | 0.98 | ALDH1A1 (0.65) | LTA4HALDH1A1RECQLMEN1USP2 | |
| Phenoxyethanol SCHEMBL20163307 | 0.96 | ALDH1A1 (0.66) | LTA4HALDH1A1RECQLMEN1USP2 | |
| Phenoxyethanol SCHEMBL28894822 | 0.95 | ALDH1A1 (0.63) | LTA4HALDH1A1RECQLMEN1USP2 | |
| Di(Hydroxyethyl)Ether SCHEMBL2485682 | 0.93 | LTA4H (0.64) | LTA4HALDH1A1RECQLMEN1USP2 | |
| Di(Hydroxyethyl)Ether SCHEMBL2482141 | 0.93 | LTA4H (0.64) | LTA4HALDH1A1RECQLMEN1USP2 | |
| Hexaethylene Glycol SCHEMBL11084821 | 0.91 | ALDH1A1 (0.66) | LTA4HALDH1A1RECQLMEN1USP2 | |
| Triethylene Glycol SCHEMBL2484230 | 0.91 | ALDH1A1 (0.66) | LTA4HALDH1A1RECQLMEN1USP2 | |
| Tetraethylene Glycol SCHEMBL2487341 | 0.91 | ALDH1A1 (0.66) | LTA4HALDH1A1RECQLMEN1USP2 | |
| SCHEMBL28323872 | 0.91 | LTA4H (0.62) | LTA4HALDH1A1RECQLMEN1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110072856-B | Process for producing alpha-hydroxycarboxylic acid dimer cyclic ester | 株式会社吴羽 | 2022-03-15 | — | — | CN | disclosed |
| CN-111699179-B | Method for producing cyclic ester | 株式会社吴羽 | 2021-09-17 | — | — | CN | disclosed |
| CN-111741953-B | Method for producing glycolide | 株式会社吴羽 | 2021-05-28 | — | — | CN | disclosed |
| CN-111757873-A | Method for producing glycolide | 株式会社吴羽 | 2020-10-09 | — | — | CN | disclosed |
| CN-111741953-A | Method for producing glycolide | 株式会社吴羽 | 2020-10-02 | — | — | CN | disclosed |
| CN-111741952-A | Method for producing glycolide | 株式会社吴羽 | 2020-10-02 | — | — | CN | disclosed |
| CN-111699179-A | Method for producing cyclic ester | 株式会社吴羽 | 2020-09-22 | — | — | CN | disclosed |
| WO-2019181516-A1 | GLYCOLIDE PRODUCTION METHOD | 株式会社クレハ | 2019-09-26 | — | — | WO | disclosed |
| WO-2019181298-A1 | METHOD FOR PRODUCING GLYCOLIDE | 株式会社クレハ | 2019-09-26 | — | — | WO | disclosed |
| WO-2019181340-A1 | GLYCOLIDE PRODUCTION METHOD | 株式会社クレハ | 2019-09-26 | — | — | WO | disclosed |
| EP-2377858-A1 | METHOD FOR PRODUCING GLYCOLIDE | Kureha Corporation (JP) | 2011-10-19 | — | — | EP | disclosed |
| US-7812181-B2 | Process for producing glycolide and glycolic acid oligomer for production of glycolide | KUREHA CORPORATION (JP) | 2010-10-12 | — | — | US | disclosed |
| US-20070293653-A1 | depolymerizing polyglycolic acid by heating in an organic solvent; system is controlled to suppress efffective concentration of impurities (ammonia, amines or amides, methoxyacetic acid and diglycolic acid); high purity glycolide starting material for polyglycolic acid | KUREHA CORPORATION (JP) | 2007-12-20 | — | — | US | disclosed |
| EP-1310496-B1 | PROCESS FOR THE PREPARATION OF CYCLIC ESTERS AND METHOD FOR PURIFICATION OF THE SAME | KUREHA CORP (JP) | 2006-12-06 | — | — | EP | disclosed |
| US-6916939-B2 | Process for the preparation of cyclic esters and method for purification of the same | KUREHA KAGAKU KOGYO K.K. (JP) | 2005-07-12 | — | — | US | disclosed |
| EP-0735403-B1 | Liquid crystal orienting agent | JSR CORP (JP) | 2004-03-17 | — | — | EP | disclosed |
| US-20030191326-A1 | Process for the preparation of cyclic esters and method for purification of the same | KUREHA CORPORATION (JP) | 2003-10-09 | — | — | US | disclosed |
| EP-1310496-A1 | PROCESS FOR THE PREPARATION OF CYCLIC ESTERS AND METHOD FOR PURIFICATION OF THE SAME | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2003-05-14 | — | — | EP | disclosed |
| US-5700860-A | Liquid crystal orienting agent | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1997-12-23 | — | — | US | disclosed |
| EP-0735403-A1 | Liquid crystal orienting agent | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1996-10-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030191326-A1 | Process for the preparation of cyclic esters and method for purification of the same | CEL, CETP, MCCC2 | LTA4H 908/4885ALDH1A1 2201/4885RECQL 4126/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.